Composite particles for toner additives
US-2024417537-A1 · Dec 19, 2024 · US
US9085651B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9085651-B2 |
| Application number | US-201313833234-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2013 |
| Priority date | Oct 19, 2010 |
| Publication date | Jul 21, 2015 |
| Grant date | Jul 21, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A silicon-based curable composition providing improved transparency, mechanical strength and resistance against heat and photo-degradation comprises at least one organopolysiloxane represented by the composition formula (1): (R 1 3 SiO 1/2 ) a (R 1 2 SiO 2/2 ) b (R 1 R 2 SiO 2/2 ) c (R 1 SiO 3/2 ) d (R 2 SiO 3/2 ) e (R 1 2 R 2 SiO 1/2 ) f (1), wherein each R 2 independently represents a methacryloxyalkyl group having 5 to 20 carbon atoms and a≧0, b≧0, c≧0, d≧0, e≧0, f≧0, c+e>0, and a+b+c+d+e+f=1; and at least one curing catalyst. The product is ideal for encapsulation of LED (light emitting device) elements.
Opening claim text (preview).
The invention claimed is: 1. A curable composition comprising (A) at least one organopolysiloxane represented by the composition formula (1): (R 1 3 SiO 1/2 ) a (R 1 2 SiO 2/2 ) b (R 1 R 2 SiO 2/2 ) c (R 1 SiO 3/2 ) d (R 2 SiO 3/2 ) e (R 1 2 R 2 SiO 1/2 ) f (1), wherein each R 1 independently represents a monovalent organic group having 1 to 20 carbon atoms or an OH group with the proviso that at each silicon-atom bearing no R 2 at least one R 1 represents a monovalent organic group having 1 to 20 carbon atoms, each R 2 independently represents a methacryloxyalkyl group having 5 to 20 carbon atoms and a, b, c, d, e, f each represent the fraction of the number of the respective units based on the number of all units of the organopolysiloxane and satisfy a 0, b 0, c≧0, d≧0, e≧0, f≧0 and also satisfy c+e>0 and a+b+c+d+e+f=1; and (B) at least one curing catalyst; and wherein the organopolysiloxane is of linear structure represented by the composition formula (3): (R 1′ 3 SiO 1/2 ) a (R 1′ 2 SiO 2/2 ) b (R 1′ R 2 SiO 2/2 ) c (3), wherein each R 1′ independently represents an unsubstituted or substituted monovalent hydrocarbon group having 1 to 20 carbon atoms, each R 2 independently represents a methacryloxyalkyl group having 5 to 20 carbon atoms and a, b, c each represent the fraction of the number of the respective units based on the number of all units of the organopolysiloxane and satisfy a>0, b>0, c>0 and a+b+c=1; and wherein the composition further comprises at least one organopolysiloxane which is of branched structure represented by the composition formula (4): (R 1′ 3 SiO 1/2 ) a (R 1′ 2 SiO 2/2 ) b (R 1′ R 2 SiO 2/2 ) c (R 1′ SiO 3/2 ) d (R 2 SiO 3/2 ) e (4), wherein each R 1′ independently represents an unsubstituted or substituted monovalent hydrocarbon group having 1 to 20 carbon atoms, each R 2 independently represents a methacryloxyalkyl group having 5 to 20 carbon atoms and a, b, c, d, e each represent the fraction of the number of the respective units based on the number of all units of the organopolysiloxane and satisfy a>0, b≧0, c≧0, d≧0, e>0 and a+b+c+d+e=1. 2. The curable composition according to claim 1 , wherein the weight ratio of organopolysiloxanes represented by composition formula (3) to organopolysiloxanes represented by composition formula (4) is from 1:5 to 3:1. 3. The curable composition according to claim 1 , wherein the curable composition further comprises at least one oligomeric siloxane of cyclic structure represented by the formula (5): (R 1′ 2 SiO 2/2 ) m (R 1′ R 2 SiO 2/2 ) n (5), wherein each R 1′ independently represents an unsubstituted or substituted monovalent hydrocarbon group having 1 to 20 carbon atoms, each R 2 independently represents a methacryloxyalkyl group having 5 to 20 carbon atoms and m and n each represent the number of the respective units, and m is an integer from 0 to 5, n is an integer from 1 to 5 and 3≦m+n≦9. 4. The curable composition according to claim 1 , wherein each R 2 represents a methacryloxy(n-propyl) group. 5. The curable composition according to claim 1 , wherein the total amount of all organopolysiloxanes is from 20 to 80 wt %, based on the total weight of the curable composition. 6. The curable composition according to claim 1 , wherein the composition comprises at least one methacrylate monomer represented by formula (2): (H 2 C═C(CH 3 )COO) z R 3 (2), wherein z is 1, 2 or 3 and R 3 represents a z-valent substituted or unsubstituted hydrocarbon residue the main chain of which may comprise one or more oxygen atoms. 7. The curable composition according to claim 6 , wherein the methacrylate monomer is selected from polyethylene glycol dimethacrylate, citronellyl methacrylate, hydroxypropyl methacrylate, hexanediol dimethacrylate, trimethylolpropanyl trimethacrylate, tetrahydrodicyclopentadienyl methacrylate, triethylene glycol dimethacrylate, isobornyl methacrylate, dicyclopentanyl methacrylate, cyclohexane dimethanol dimethacrylate, tricyclodecane dimethanol dimethacrylate and mixtures thereof. 8. The curable composition according to claim 6 , wherein the weight ratio of the total amount of organopolysiloxanes to the total amount of methacrylate monomers is from 3:1 to 1:3. 9. The curable composition according to claim 1 , wherein the curing catalyst is selected from benzyl peroxide, t-butyl perbenzoate, o-methylbenzyl peroxide, di-t-butyl peroxide, dicumyl peroxide, 1,1-bis(t-butylperoxy)-3,3,5-trimethyl cyclohexane, 1,1-di(t-butylperoxy) cyclohexane, 2,5-dimethyl-2,5-di(t-butylperoxy) hexane, 2,5-dimethyl-2,5-di(t-butylperoxy)hexane, di(4-methylbenzoylperoxy)hexamethylene biscarbonate, 1,1-di-(tert-amyl peroxy)cyclohexane and mixtures thereof. 10. A curable composition according to claim 1 as an encapsulant for LED (light emitting devices). 11. A LED (light emitting device) encapsulated by the cured product of a curable composition according to claim 1 .
Related publications grouped by family.
Answers are generated from the same data shown on this page.